can you use ddp4 and glp 1 together GLP-1 receptor agonist versus DPP-4 inhibitor kidney and cardiovascular outcomes in clinical practice in type-2 diabetes Expert Consensus on Dipeptidyl Peptidase-4

What do you think about the use of GLP-1s to treat SUD

Samols E, Tyler J, Megyesi C, Marks V

When sotaglifozin was administered (30 mg/kg/d for 6 weeks) in obese rats, with metabolic-syndrome-related models of HF with HFpEF, and wild-type rats, this treatment ameliorated left atrial enlargement in HFpEF in vivo, prevented mitochondrial swelling, enhanced mitochondrial Ca 2+ buffer capacity in HFpEF, improved mitochondrial fission and reactive oxygen species (ROS) production during glucose starvation, and averted Ca 2+ accumulation upon glycolytic inhibition [122]

The good news is these side effects tend to decrease and go away within the first two months

they directly affect peoples health

Focus on form